Abstract
Does age-adjusted Charlson comorbidity score skew survival endpoints in women with FIGO-stage III endometrial cancer?
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have